Treating Depression in Alzheimer Disease
Archives of General Psychiatry2003Vol. 60(7), pp. 737–737
Citations Over TimeTop 1% of 2003 papers
Constantine G. Lyketsos, Lourdes DelCampo, Martin H. Steinberg, Quincy Samus Miles, Cynthia D. Steele, Cynthia A. Munro, Alva Baker, Jeannie‐Marie E. Sheppard, Constantine Frangakis, Jason Brandt, Peter V. Rabins
Abstract
Sertraline is superior to placebo for the treatment of major depression in Alzheimer disease. Depression reduction is accompanied by lessened behavior disturbance and improved activities of daily living, but not improved cognition.
Related Papers
- → Fluoxetine Treatment of Patients With Major Depressive Disorder Who Failed Initial Treatment With Sertraline(1997)205 cited
- → An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression(2003)166 cited
- → Multicenter Open‐Label Sertraline Study in Adolescent Outpatients With Major Depression(1999)88 cited
- → Use of the Hamilton rating scale for depression and the Carroll self-rating scale in adolescents(1985)24 cited
- → The effect of early anti-depression treatment with sertraline on post-stroke depression and blood serotonin level(2008)